Amgen Announces New Data Being Presented At ASH 2020

Author's Avatar
Dec 01, 2020
Article's Main Image

Data From Innovative BiTE® Platform Include First Clinical Data for AMG 701 and Analyses From BLINCYTO® (blinatumomab) Phase 3 Pediatric Study

New KYPROLIS® (carfilzomib) Progression-Free Survival Data From the Phase 3 CANDOR Study

PR Newswire